Clinical features and immune mechanisms directly linked to the altered liver function in patients with rheumatoid arthritis.

[1]  N. Barbarroja,et al.  Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk , 2022, Frontiers in Immunology.

[2]  E. C. Sayre,et al.  Using FibroScan to Assess for the Development of Liver Fibrosis in Patients With Arthritis on Methotrexate: A Single-center Experience , 2022, The Journal of Rheumatology.

[3]  W. Robinson,et al.  Pathogenic Role of Circulating Citrullinated Antigens and Anti-Cyclic Monoclonal Citrullinated Peptide Antibodies in Rheumatoid Arthritis , 2021, Frontiers in Immunology.

[4]  A. Wakhlu,et al.  Prevalence of liver fibrosis by Fibroscan in patients on long-term methotrexate therapy for rheumatoid arthritis , 2021, Clinical Rheumatology.

[5]  M. Wiese,et al.  Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs , 2020, Scientific Reports.

[6]  C. Costea,et al.  The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD) , 2020, Journal of diabetes research.

[7]  T. Harzy,et al.  Liver fibrosis in rheumatoid arthritis patients treated with methotrexate. , 2020, Current rheumatology reviews.

[8]  N. Eriksson,et al.  Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long‐term follow‐up of predictors, surveillance, and outcome in clinical practice , 2019, International journal of rheumatic diseases.

[9]  C. Mantzoros,et al.  Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. , 2019, Metabolism: clinical and experimental.

[10]  Ming-Chi Lu,et al.  The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis , 2019, Ci ji yi xue za zhi = Tzu-chi medical journal.

[11]  S. Mori,et al.  Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment , 2018, PloS one.

[12]  N. Barbarroja,et al.  Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues , 2018, Journal of internal medicine.

[13]  Biljana Radovanović-Dinić,et al.  Clinical connection between rheumatoid arthritis and liver damage , 2018, Rheumatology International.

[14]  V. Pīrāgs,et al.  Fatty liver index and hepatic steatosis index for prediction of non‐alcoholic fatty liver disease in type 1 diabetes , 2018, Journal of gastroenterology and hepatology.

[15]  J. Salazar,et al.  Optimal cutoff for the evaluation of insulin resistance through triglyceride-glucose index: A cross-sectional study in a Venezuelan population [version 1; referees: awaiting peer review] , 2017 .

[16]  S. Saevarsdottir,et al.  Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial , 2017, RMD Open.

[17]  S. Rajagopal,et al.  PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis , 2017, Expert opinion on therapeutic targets.

[18]  Xuefeng Yu,et al.  The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease , 2017, Lipids in Health and Disease.

[19]  K. Lindor,et al.  The management of autoimmunity in patients with cholestatic liver diseases , 2016, Expert review of gastroenterology & hepatology.

[20]  Wei Zhang,et al.  [Screening of citrullinated proteins in ten tumor cell lines]. , 2015, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[21]  N. Barbarroja,et al.  Anticyclic Citrullinated Protein Antibodies Are Implicated in the Development of Cardiovascular Disease in Rheumatoid Arthritis , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[22]  N. Sattar,et al.  Non-alcoholic fatty liver disease , 2014, BMJ : British Medical Journal.

[23]  Y. Oo,et al.  Innate Immune Cells in Liver Inflammation , 2012, Mediators of inflammation.

[24]  C. Selmi,et al.  Liver involvement in subjects with rheumatic disease , 2011, Arthritis research & therapy.

[25]  Ying Sun,et al.  Performance of the aspartate aminotransferase‐to‐platelet ratio index for the staging of hepatitis C‐related fibrosis: An updated meta‐analysis , 2011, Hepatology.

[26]  K. Kowdley,et al.  Rheumatologic disease and the liver. , 2011, Clinics in liver disease.

[27]  H. Kim,et al.  Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[28]  S. Sánchez-Ramón,et al.  Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[29]  P. Dessein,et al.  High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis. , 2008, Clinical and experimental rheumatology.

[30]  E. Choi.  Oxidative status of DBA/1J mice with type II collagen‐induced arthritis , 2007, Journal of applied toxicology : JAT.

[31]  J. Montaner,et al.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.

[32]  G. Targher,et al.  Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. , 2005, Diabetes.

[33]  M. Pfaffl,et al.  Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper – Excel-based tool using pair-wise correlations , 2004, Biotechnology Letters.

[34]  Erick M Remer,et al.  The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.

[35]  M. Karsdal,et al.  Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathology. , 2012, American journal of translational research.

[36]  Yvonne C. Lee.  Effect and Treatment of Chronic Pain in Inflammatory Arthritis , 2012, Current Rheumatology Reports.

[37]  A. Silman,et al.  UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .

[38]  M. González-Gay,et al.  Anti-TNF-alpha therapy does not modulate leptin in patients with severe rheumatoid arthritis. , 2009, Clinical and experimental rheumatology.